Citigroup’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-90,172
Closed -$274K 5103
2024
Q4
$274K Buy
90,172
+13,121
+17% +$39.9K ﹤0.01% 3385
2024
Q3
$400K Buy
77,051
+52,132
+209% +$271K ﹤0.01% 3127
2024
Q2
$64K Sell
24,919
-35,592
-59% -$91.5K ﹤0.01% 3722
2024
Q1
$298K Sell
60,511
-30,777
-34% -$151K ﹤0.01% 3112
2023
Q4
$802K Buy
91,288
+42,063
+85% +$370K ﹤0.01% 2341
2023
Q3
$565K Buy
49,225
+10,517
+27% +$121K ﹤0.01% 2328
2023
Q2
$980K Buy
38,708
+26,748
+224% +$677K ﹤0.01% 2258
2023
Q1
$385K Sell
11,960
-28,908
-71% -$931K ﹤0.01% 2710
2022
Q4
$754K Sell
40,868
-30,389
-43% -$561K ﹤0.01% 2259
2022
Q3
$1.92M Buy
71,257
+46,925
+193% +$1.27M ﹤0.01% 1618
2022
Q2
$336K Buy
24,332
+11,881
+95% +$164K ﹤0.01% 2892
2022
Q1
$243K Sell
12,451
-17,759
-59% -$347K ﹤0.01% 3299
2021
Q4
$493K Buy
30,210
+1,897
+7% +$31K ﹤0.01% 3065
2021
Q3
$789K Buy
28,313
+15,095
+114% +$421K ﹤0.01% 2569
2021
Q2
$392K Buy
13,218
+3,501
+36% +$104K ﹤0.01% 3218
2021
Q1
$271K Sell
9,717
-10,058
-51% -$281K ﹤0.01% 3188
2020
Q4
$561K Buy
19,775
+8,571
+76% +$243K ﹤0.01% 2557
2020
Q3
$281K Sell
11,204
-14,532
-56% -$364K ﹤0.01% 2591
2020
Q2
$629K Buy
25,736
+4,624
+22% +$113K ﹤0.01% 2409
2020
Q1
$313K Buy
21,112
+5,830
+38% +$86.4K ﹤0.01% 2579
2019
Q4
$248K Sell
15,282
-11,657
-43% -$189K ﹤0.01% 3025
2019
Q3
$350K Buy
26,939
+1,118
+4% +$14.5K ﹤0.01% 2769
2019
Q2
$335K Sell
25,821
-1,016
-4% -$13.2K ﹤0.01% 2925
2019
Q1
$423K Buy
26,837
+6,729
+33% +$106K ﹤0.01% 2619
2018
Q4
$405K Buy
20,108
+11,532
+134% +$232K ﹤0.01% 2660
2018
Q3
$213K Buy
8,576
+8,369
+4,043% +$208K ﹤0.01% 3116
2018
Q2
$6K Sell
207
-137
-40% -$3.97K ﹤0.01% 4724
2018
Q1
$11K Sell
344
-60
-15% -$1.92K ﹤0.01% 4461
2017
Q4
$14K Buy
404
+127
+46% +$4.4K ﹤0.01% 4387
2017
Q3
$8K Buy
277
+37
+15% +$1.07K ﹤0.01% 4268
2017
Q2
$6K Sell
240
-73
-23% -$1.83K ﹤0.01% 4299
2017
Q1
$7K Buy
313
+44
+16% +$984 ﹤0.01% 4399
2016
Q4
$6K Hold
269
﹤0.01% 4624
2016
Q3
$4K Sell
269
-6,089
-96% -$90.5K ﹤0.01% 4700
2016
Q2
$86K Sell
6,358
-6,413
-50% -$86.7K ﹤0.01% 3416
2016
Q1
$223K Buy
12,771
+2,115
+20% +$36.9K ﹤0.01% 3387
2015
Q4
$364K Buy
10,656
+10,647
+118,300% +$364K ﹤0.01% 2610
2015
Q3
$0 Sell
9
-3,295
-100% ﹤0.01% 5580
2015
Q2
$106K Sell
3,304
-1,434
-30% -$46K ﹤0.01% 3209
2015
Q1
$98K Sell
4,738
-3,102
-40% -$64.2K ﹤0.01% 3417
2014
Q4
$133K Buy
7,840
+7,540
+2,513% +$128K ﹤0.01% 3457
2014
Q3
$6K Buy
300
+242
+417% +$4.84K ﹤0.01% 4865
2014
Q2
$2K Sell
58
-1,051
-95% -$36.2K ﹤0.01% 5145
2014
Q1
$35K Buy
+1,109
New +$35K ﹤0.01% 4195